Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)
  7. Department of Pathology and Laboratory Medicine (416)
  8. Gastrointestinal Oncology Service (387)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiation shielding for diagnostic radiology
    Journal Article

    Dauer, L. T.
    Radiation Protection Dosimetry (2012)

    Fulltext@MSK | Save
  • Clinical activity and safety of anti-programmed death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in patients (pts) with advanced melanoma (MEL)
    Meeting Abstract

    Sosman, J.; Sznol, M.; McDermott, D. F.; Carvajal, R.; Lawrence, D. P.; Topalian, S. L.; Wigginton, J. M.; Kollia, G.; Gupta, A.; Hodi, F. S.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • ARN-509 in men with high risk non-metastatic castration-resistant prostate cancer
    Meeting Abstract

    Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W.; Shore, N. D.; Liu, G.; Alumkal, J.; Higano, C.; Chow-Maneval, E.; Rathkopf, D.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Association of baseline corticosteroid with outcomes in a multivariate analysis of the phase 3 AFFIRM study of enzalutamide (ENZA), an androgen receptor signaling inhibitor (ARSI)
    Meeting Abstract

    Scher, H. I.; Fizazi, K.; Saad, F.; Chi, K.; Taplin, M.; Sternberg, C. N.; Armstrong, A. J.; Hirmand, M.; Selby, B.; de Bono, J. S.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • A large retrospective analysis of pemetrexed (PEM) activity in patients (pts) with ALK-positive (ALK+) non-small cell lung cancer (NSCLC) prior to crizotinib (CRIZ) treatment
    Meeting Abstract

    Scagliotti, G.; Kim, D. W.; Shaw, A. T.; Ou, S. I.; Riely, G. J.; Gettinger, S.; Besse, B.; Wilner, K.; Tang, Y.; Bartlett, C. H.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Association of radiographic progression-free survival (rPFS) adapted from Prostate Cancer Working Group 2 (PCWG2) consensus criteria (APCWG2) with overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302
    Meeting Abstract

    Ryan, C. J.; Morris, M.; Molina, A.; Piulats, J. R.; De Souza, P.; Li, J.; Kheoh, T.; de Bono, J. S.; Larson, S.; Griffin, T.; more...
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Genes, chromosomes and the treatment of bladder cancer
    Meeting Abstract

    Rosenberg, J. E.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Sunitinib treatment of renal adjuvant cancer (S-TRAC): A randomized, double-blind, phase III study of sunitinib vs. placebo in subjects at high risk of recurrent renal cell carcinoma (RCC)
    Meeting Abstract

    Ravaud, A.; Motzer, R. J.; Pandha, H.; Staehler, M.; George, D. J.; Pantuck, A.; Patel, A.; Gerletti, P.; Chen, L.; Patard, J.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • ARN-509 in men with metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R.; Alumkal, J.; Ryan, C. J.; Saleh, M.; Hauke, R.; Chow-Maneval, E.; Scher, H. I.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Biomarkers of everolimus efficacy in patients with metastatic renal cell carcinoma (mRCC): Analysis of the phase III RECORD-1 trial
    Meeting Abstract

    Oudard, S.; Escudier, B.; Thompson, J.; Grünwald, V.; Conte, P. F.; Bracarda, S.; Panneerselvam, A.; Gogov, S.; Chen, D.; Motzer, R. J.
    Annals of Oncology (2012)

    Fulltext@MSK | Save